EU Waives Fix For Takeda's £46B Shire Deal
Europe's competition watchdog said Thursday that Takeda Pharmaceutical Co. Ltd. will not have to sell a biologic drug it agreed to shed for approval of its £46 billion ($56.7 billion) purchase...To view the full article, register now.
Already a subscriber? Click here to view full article